Clinical trials
Phase 2 Burkitt Lymphoma trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2019 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fred Hutchinson Cancer Center | 3 |
| Novartis Pharmaceuticals | 3 |
| Amgen Research (Munich) GmbH | 1 |
| Andres J. M. Ferreri | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| German High-Grade Non-Hodgkin's Lymphoma Study Group | 1 |
| Kite, A Gilead Company | 1 |
| Northern Italy Leukemia Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Burkitt Lymphoma | 12 |
| Lymphoma, Follicular | 6 |
| Lymphoma, Large B-Cell, Diffuse | 6 |
| Lymphoma, Non-Hodgkin | 6 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Leukemia, Hairy Cell | 5 |
| Lymphoma, Large-Cell, Immunoblastic | 5 |
| Waldenstrom Macroglobulinemia | 5 |
| Hodgkin Disease | 4 |
| Immunoblastic Lymphadenopathy | 4 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.